CE IVDR Self-Test | OTC-Ready | 5-in-1

MAK-5
Multipathogen Antigen Self-Test Kit

CE IVDR Class C self-test for lay-user application. Suitable for OTC-oriented channels. Detects five respiratory viruses from an anterior nasal swab in ~15 minutes. See IFU for intended use, performance and limitations.

SP-Asia MAK-5

Why 5-in-1 Respiratory Testing Matters

01

Beyond COVID + Flu

Many respiratory symptoms are not caused by COVID-19 or influenza. Broader testing reduces the blind spots and improve treatments.
For easy patient home-/self-testing

02

RSV Included

RSV is a major seasonal respiratory pathogen and can be clinically relevant in children, older adults and vulnerable groups. ECDC highlighted RSV activity together with influenza during the 2024/2025 winter season in the EU/EEA.

03

Adenovirus Included

Adenovirus is frequently overlooked in respiratory testing despite causing symptoms that can resemble bacterial infections. Including Adenovirus in the MAK-5 panel helps close an important diagnostic gap, supporting better differentiation of viral respiratory illnesses and helping avoid unnecessary assumptions about bacterial causes.


What pathogens does MAK-5 detect?

SARS-CoV-2

SARS-CoV-2

Rapid antigen detection of SARS-CoV-2 to support respiratory self-testing and differentiation from other common respiratory pathogens.

Influenza_A

Flu A

Detects Influenza A antigen as part of a combined respiratory panel, supporting faster awareness during flu seasons and mixed outbreaks.

Influenza_B

Flu B

Identifies influenza B variants swiftly to differentiate co-circulating flu outbreaks and reduce misdiagnosis with other respiratory pathogens.

RSV

RSV

Detects RSV antigen, relevant for children, older adults and vulnerable groups where respiratory infections may require closer attention.

ADV

ADV

Screens for common adenovirus respiratory infections that often mimic influenza or bacterial infections, supporting better clinical differentiation and treatment.


MAK-5_One_Sample_One_Well

One Sample Well. Five Results.

MAK-5 is designed for simplicity. Thanks to its patented bidirectional flow technology, one prepared sample is added into a single sample well and distributed across the test card for detection of all five target pathogens: SARS-CoV-2, Influenza A, Influenza B, RSV and Adenovirus.

This reduces handling steps compared with multi-well test designs and helps minimize user error — an important advantage for home users, elderly users, pharmacies and OTC-oriented distribution.


Most simple and convenient way to use – in just one swab!

Always follow the Instructions for Use (IFU). Training available upon request.


Intended Use & Specifications

  • Specimen: Anterior nasal swab
  • Readout: Lateral flow immunoassay
  • Storage condition: 2~30℃ (as per IFU)
  • Shelf life: 24 months (see label)
  • Certification: IVDR CE Class C self-test, ISO13485
  • Disposal: Per local regulations
  • Availability: Europe, SEA & AUNZ (contact us)

MAK-5 outperforms similar tests with great accuracy

Sensitivity

High Sensitivity
Validated clinical performance across all five target pathogens, with high sensitivity.

Specificity

Exceptional Specificity
Proven high accuracy ensuring reliable differentiation between similar respiratory infections and reducing false positives.

Time to Result

Rapid Results
Clear, easy-to-read outcomes in 15 minutes — enabling faster clinical decisions and improved patient management vs. alternative methods.

CE-IVDR Class C self-test for lay-user application. Suitable for OTC-oriented channels, pharmacies, retail and home-testing programs where permitted by local regulation.


MAK-5 Technical Information

Regulatory note: MAK-5 is positioned as consumer self-test and OTC-ready. Market access, sales channels and claims depend on local registration requirements.


What’s included in the MAK-5?

MAK5_content SP-Asia

Test Cassettes

Individually packed, ready-to-use rapid antigen strips pre-coated for five-pathogen detection.

Extraction Buffer

Optimized reagent ensuring stable antigen release and consistent performance.

Swabs

High-absorbency, individually sealed, suitable for nasal or nasopharyngeal collection.

IFU

Step-by-step illustrated guide ensuring correct handling and interpretation.


Study Experience

VACCELERATE Europe

MAK-5 was used in two German VACCELERATE pilot studies published among others in Frontiers in Public Health to evaluate self-testing for five respiratory viruses in adult volunteers as well as senior citizens in particular.

Self-testing enables real-time reporting

During one winter season, 1,429 participants communicated self-testing results. Among symptomatic participants, SARS-CoV-2, RSV and Influenza A were the most frequently detected pathogens. The study concluded that self-testing enabled real-time reporting of five endemic acute respiratory infection pathogens in a citizen-science setting.

Key Points

German/EU VACCELERATE volunteer registry studies
Five respiratory pathogens monitored
Published in Frontiers in Public Health and Clinical Microbiology and Infection CMI
Supports real-world relevance of multipathogen self-testing
Special focus on senior citizens in Germany

Downloads


Contact Us

Address

50 Kaki Bukit Place, #04-01, 415926 Singapore

Send Us a Message

Here’s how you can contact us for any questions or concerns.

info@sp-asia.com
+65 6235 5337
Name
Email
Message
The form has been submitted successfully!
There has been some error while submitting the form. Please verify all form fields again.

References

Frontiers in Public Health:

Webinar: MAK5-50+ results (German, with subtitles)



Frequently Asked Questions

Scroll to Top